Does addition of metoclopramide to lignocaine confer additional advantage on reducing pain on propofol injection?

Background: Intravenous injection of lipid emulsion propofol induces a considerable degree of pain and the most preferred treatment suggested is pretreatment with intravenous lignocaine to alleviate such pain. The present study was designed to evaluate whether addition of metoclopramide to lignocain...

Full description

Bibliographic Details
Main Authors: Girija Kumari B, Samantaray A, Geeta K, Durga P, Ramchandran G, Kiran Kumar A, Jagadeesh G
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Journal of Clinical and Scientific Research
Subjects:
Online Access:http://svimstpt.ap.nic.in/jcsr/jan-mar15_files/3oa15.pdf
_version_ 1828439263797051392
author Girija Kumari B
Samantaray A
Geeta K
Durga P
Ramchandran G
Kiran Kumar A
Jagadeesh G
author_facet Girija Kumari B
Samantaray A
Geeta K
Durga P
Ramchandran G
Kiran Kumar A
Jagadeesh G
author_sort Girija Kumari B
collection DOAJ
description Background: Intravenous injection of lipid emulsion propofol induces a considerable degree of pain and the most preferred treatment suggested is pretreatment with intravenous lignocaine to alleviate such pain. The present study was designed to evaluate whether addition of metoclopramide to lignocaine offers any advantage over lignocaine alone as a pretreatment in prevention of pain following propofol injection. Methods: In this prospective, randomized, double-blind controlled study, 60 patients were randomized to receive either lignocaine (group A) or lignocaine with metoclopramide (group B) intravenously as a pretreatment before injection of propofol. Pain due to injection of propofol was assessed with a four point categorical verbal rating pain scale. The incidence and magnitude of pain was compared between the two groups. Results: There was no statistically significant difference in the perceived intensity of pain between the two groups at different time points after administration of propofol. The incidence of moderate pain was 23.3% in group A and 20% in group B (p = 0.211); 26.7% patients in group A and 43.3% patients in group B had no pain during propofol administration (p = 0.116). Conclusions: Addition of metoclopramide to lignocaine does not have additional advantage over lignocaine alone in alleviating the pain of emulsified propofol injection.
first_indexed 2024-12-10T20:20:18Z
format Article
id doaj.art-55a9b53dcd6b48d9ac8d1e739b094d1f
institution Directory Open Access Journal
issn 2277-5706
2277-8357
language English
last_indexed 2024-12-10T20:20:18Z
publishDate 2015-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Clinical and Scientific Research
spelling doaj.art-55a9b53dcd6b48d9ac8d1e739b094d1f2022-12-22T01:35:04ZengWolters Kluwer Medknow PublicationsJournal of Clinical and Scientific Research2277-57062277-83572015-01-01411621http://dx.doi.org/10.15380/2277-5706.JCSR.13.060Does addition of metoclopramide to lignocaine confer additional advantage on reducing pain on propofol injection?Girija Kumari B0Samantaray A1Geeta K2Durga P3Ramchandran G4Kiran Kumar A5Jagadeesh G6Balaji Institute of Surgery Research Rehabilitation for Disabled, Tirupati Sri Venkateswara Institute of Medical Sciences, TirupatiNizam’s Institute of Medical Sciences, Hyderabad Nizam’s Institute of Medical Sciences, Hyderabad Nizam’s Institute of Medical Sciences, Hyderabad Sri Venkateswara Institute of Medical Sciences, TirupatiBalaji Institute of Surgery Research Rehabilitation for DisabledBackground: Intravenous injection of lipid emulsion propofol induces a considerable degree of pain and the most preferred treatment suggested is pretreatment with intravenous lignocaine to alleviate such pain. The present study was designed to evaluate whether addition of metoclopramide to lignocaine offers any advantage over lignocaine alone as a pretreatment in prevention of pain following propofol injection. Methods: In this prospective, randomized, double-blind controlled study, 60 patients were randomized to receive either lignocaine (group A) or lignocaine with metoclopramide (group B) intravenously as a pretreatment before injection of propofol. Pain due to injection of propofol was assessed with a four point categorical verbal rating pain scale. The incidence and magnitude of pain was compared between the two groups. Results: There was no statistically significant difference in the perceived intensity of pain between the two groups at different time points after administration of propofol. The incidence of moderate pain was 23.3% in group A and 20% in group B (p = 0.211); 26.7% patients in group A and 43.3% patients in group B had no pain during propofol administration (p = 0.116). Conclusions: Addition of metoclopramide to lignocaine does not have additional advantage over lignocaine alone in alleviating the pain of emulsified propofol injection.http://svimstpt.ap.nic.in/jcsr/jan-mar15_files/3oa15.pdf: LignocaineMetoclopramidePropofolPain
spellingShingle Girija Kumari B
Samantaray A
Geeta K
Durga P
Ramchandran G
Kiran Kumar A
Jagadeesh G
Does addition of metoclopramide to lignocaine confer additional advantage on reducing pain on propofol injection?
Journal of Clinical and Scientific Research
: Lignocaine
Metoclopramide
Propofol
Pain
title Does addition of metoclopramide to lignocaine confer additional advantage on reducing pain on propofol injection?
title_full Does addition of metoclopramide to lignocaine confer additional advantage on reducing pain on propofol injection?
title_fullStr Does addition of metoclopramide to lignocaine confer additional advantage on reducing pain on propofol injection?
title_full_unstemmed Does addition of metoclopramide to lignocaine confer additional advantage on reducing pain on propofol injection?
title_short Does addition of metoclopramide to lignocaine confer additional advantage on reducing pain on propofol injection?
title_sort does addition of metoclopramide to lignocaine confer additional advantage on reducing pain on propofol injection
topic : Lignocaine
Metoclopramide
Propofol
Pain
url http://svimstpt.ap.nic.in/jcsr/jan-mar15_files/3oa15.pdf
work_keys_str_mv AT girijakumarib doesadditionofmetoclopramidetolignocaineconferadditionaladvantageonreducingpainonpropofolinjection
AT samantaraya doesadditionofmetoclopramidetolignocaineconferadditionaladvantageonreducingpainonpropofolinjection
AT geetak doesadditionofmetoclopramidetolignocaineconferadditionaladvantageonreducingpainonpropofolinjection
AT durgap doesadditionofmetoclopramidetolignocaineconferadditionaladvantageonreducingpainonpropofolinjection
AT ramchandrang doesadditionofmetoclopramidetolignocaineconferadditionaladvantageonreducingpainonpropofolinjection
AT kirankumara doesadditionofmetoclopramidetolignocaineconferadditionaladvantageonreducingpainonpropofolinjection
AT jagadeeshg doesadditionofmetoclopramidetolignocaineconferadditionaladvantageonreducingpainonpropofolinjection